When BDNF and Pro-BDNF levels were evaluated in subgroups of ALS patients, stratified by clinical and genetic features, a significant difference between C9orf72 expansion carriers and non-carriers emerged. The gene discussed is BDNF; the disease is amyotrophic lateral sclerosis.